Veracyte officer has 3,961 shares withheld for tax

Veracyte’s Global Chief Commercial Officer had shares withheld for taxes on RSU vesting, leaving him with 128,344 directly held shares.

Rhea-AI Filing Summary

VERACYTE, INC. (VCYT) reported an insider equity event involving Global Chief Commercial Officer John Leite. On September 2, 2026, Leite had 3,961 shares of common stock withheld at $44.88 per share to satisfy tax withholding obligations tied to vesting restricted stock units.

The filing states this was a tax-withholding disposition and not an open-market sale. After this transaction, Leite directly held 128,344 shares of Veracyte common stock. No transactions were made under a Rule 10b5-1 trading plan.

Insider Trade Summary

Tax Withholding: 3,961 shares

Tax Withholding 1 txn

Insider Leite John

Role Global Chief Commercial Off

Type	Security	Shares	Price	Value
Tax Withholding	Common Stock F1	3,961	$44.88	$178K

Holdings After Transaction: Common Stock — 128,344 shares (Direct)

Footnotes (1)

1. F1. Represents shares of common stock withheld to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of certain restricted stock units on September 2, 2026 and does not represent a sale.

Key Figures

Shares withheld for taxes: 3,961 shares Withholding reference price: $44.88 per share Shares held after transaction: 128,344 shares

3 metrics

Shares withheld for taxes 3,961 shares Common stock withheld on September 2, 2026 for tax withholding obligations

Withholding reference price $44.88 per share Price used for the 3,961 common shares withheld on September 2, 2026

Shares held after transaction 128,344 shares Directly held Veracyte common stock by John Leite following the transaction

Key Terms

restricted stock units, tax withholding obligations, Form 4

3 terms

restricted stock units financial

"in connection with the vesting of certain restricted stock units on September 2, 2026"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

tax withholding obligations financial

"withheld to satisfy the Reporting Person's tax withholding obligations"

Form 4 regulatory

"as reported in the Form 4"

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did VCYT report for John Leite on September 2, 2026?

Veracyte reported that Global Chief Commercial Officer John Leite had 3,961 shares of common stock withheld on September 2, 2026 to cover tax withholding obligations from vesting restricted stock units. The filing specifies this does not represent a sale.

How many VCYT shares were involved and at what price?

The transaction involved 3,961 shares of Veracyte common stock at $44.88 per share. These shares were withheld to satisfy tax withholding obligations in connection with the vesting of restricted stock units.

How many VERACYTE (VCYT) shares does John Leite hold after this transaction?

After the September 2, 2026 tax-withholding transaction, Global Chief Commercial Officer John Leite directly held 128,344 shares of Veracyte common stock, as reported in the Form 4.

Was the VCYT insider transaction an open-market sale?

No. The Form 4 footnote states the 3,961 shares represent stock withheld for tax withholding obligations related to vesting restricted stock units and do not represent a sale in the open market.

Was Veracyte’s Form 4 transaction under a Rule 10b5-1 trading plan?

No. The filing’s Rule 10b5-1 checkbox is unchecked, and there is no footnote indicating that the September 2, 2026 transaction was made under any Rule 10b5-1 trading plan.

What is John Leite’s role at VERACYTE, INC. (VCYT)?

The Form 4 identifies John Leite as an officer of Veracyte, serving as Global Chief Commercial Off (Global Chief Commercial Officer).

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/04/2026 - 07:54 PM EDT Accepted by SEC EDGAR 09/04/2026 - 07:54 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Leite John

(Last) (First) (Middle)

6000 SHORELINE COURT, SUITE 300

(Street)

SOUTH SAN FRANCISCO CALIFORNIA 94080

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
VERACYTE, INC. [ VCYT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Global Chief Commercial Off

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
09/02/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/02/2026		F(1)		3,961	D	$44.88	128,344	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents shares of common stock withheld to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of certain restricted stock units on September 2, 2026 and does not represent a sale.

Remarks:

	/s/ Jonathan Wygant, as attorney-in-fact	09/04/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)